Keyphrases
Thyroid Cancer
100%
Cancer Resistance
100%
Vitamin D Receptor
100%
24-hydroxylase
100%
Vitamin D Receptor Activation
100%
FokI Polymorphism
100%
Calcitriol
60%
Agonist Treatment
50%
Vitamin D Receptor Activator
50%
CYP27B1
30%
FokI
30%
MRNA Expression
20%
Relative Resistance
20%
Well-differentiated Thyroid Cancer
20%
Calcitriol Treatment
20%
Vitamin D Receptor Gene Polymorphism
20%
Thyroid Cancer Cell Lines
20%
Thyroid Cancer Cells
20%
Cancer Therapy
10%
Cell Count
10%
Cell Growth
10%
Cell Proliferation
10%
Cancer Risk
10%
Receptor-interacting Protein Kinase 1 (RIPK1)
10%
Ligand-receptor Binding
10%
Days of Treatment
10%
Genetic Markers
10%
Western Blot
10%
Proliferation in Vitro
10%
Tissue Type
10%
Novel Therapeutic Targets
10%
Viable Cell Count
10%
Viable Cells
10%
Cell-based Assay
10%
Resistant Cells
10%
Tumor Growth in Vivo
10%
Vitamin D Receptor Genotype
10%
Receptor Transactivation
10%
TPC1
10%
Pharmacology, Toxicology and Pharmaceutical Science
Thyroid Cancer
100%
Vitamin D Receptor
100%
Oxygenase
100%
Cancer Resistance
100%
Calcitriol
42%
Receptor Agonist
26%
Poorly Differentiated Thyroid Cancer
10%
Messenger RNA
10%
Tumor Growth
5%
Malignant Neoplasm
5%
Receptor Protein
5%
Western Blot
5%
Biochemistry, Genetics and Molecular Biology
Vitamin D
100%
Oxygenase
100%
FokI
100%
Calcitriol
42%
Receptor Agonists
26%
Cancer Cell
21%
Messenger RNA
10%
Cell Growth
5%
Tumor Progression
5%
Cell Proliferation
5%
Western Blot
5%
Genetic Marker
5%
Genotyping
5%
Cell Count
5%
Transactivation
5%
Cell Assay
5%
Viable Cell Count
5%